🇨🇳 Tu Youyou

In 1969, a 39-year-old Chinese pharmaceutical researcher received a secret assignment. The Vietnam War was killing soldiers on both sides, but a second enemy was killing more: malaria. The Plasmodium parasite had evolved resistance to chloroquine, the standard treatment of the era, and nothing in the existing drug arsenal worked reliably. North Vietnam appealed to Mao Zedong's government for help. Mao launched "Project 523" — a classified military research program tasking hundreds of scientists with finding a new malaria treatment. Among those scientists was Tu Youyou, a researcher at the China Academy of Chinese Medical Sciences in Beijing, quietly determined and largely unknown outside her field. Forty-six years later, she would accept the Nobel Prize in Physiology or Medicine in Stockholm.

Tu Youyou was born on December 30, 1930, in Ningbo, Zhejiang province. Her name — Youyou — comes from a line in the Classic of Poetry: "Youyou cries the deer, while grazing on the wild Artemisia." The plant would define her life's work. She studied pharmacy at Peking University and later specialized in traditional Chinese medicine at the China Academy. It was this unusual combination — modern pharmacological training grafted onto deep knowledge of classical herbal texts — that would make her approach uniquely powerful.

The conventional drug-discovery approach of the era scanned chemical libraries for promising compounds. Tu Youyou went in a different direction: she would search the 2,000-year history of Chinese herbal medicine for records of plants used against fever and malaria-like symptoms. She and her team reviewed over 2,000 traditional Chinese recipes and identified 640 potentially relevant compounds from 200 herbs. One candidate kept appearing in ancient texts: sweet wormwood (Artemisia annua), known in Chinese as qinghao. A fourth-century medical text by Ge Hong, Emergency Prescriptions Kept Up One's Sleeve, described soaking it in cold water and squeezing out the juice to treat intermittent fevers.

That detail — cold water, not hot — was the key. Early laboratory tests of Artemisia annua extracts produced inconsistent results. Tu Youyou realized that the standard hot-extraction process might be destroying the active compound. She redesigned the extraction protocol using low-temperature ether solvent, following Ge Hong's ancient instruction. The new extract was dramatically more effective. In 1972, she and her team isolated the pure active compound: artemisinin (qinghaosu). Its structure, once determined by X-ray crystallography, was unlike any known antimalarial — a sesquiterpene lactone containing an unusual endoperoxide bridge that turned out to be essential for its lethal action on the parasite.

Tu Youyou volunteered to be among the first human subjects when clinical trials began. The results were extraordinary: artemisinin cleared malaria parasites rapidly and with minimal side effects. It worked against both Plasmodium falciparum and Plasmodium vivax, including drug-resistant strains. It was the most potent antimalarial compound ever discovered. Artemisinin-based combination therapies (ACTs) are now the WHO's recommended first-line treatment for uncomplicated malaria worldwide. The WHO estimates that ACTs have saved more than a million lives in sub-Saharan Africa alone since 2000, and that artemisinin has contributed to a reduction in global malaria mortality of over 50% since its introduction.

For decades, Tu Youyou's contribution was little recognized outside China. Project 523 had been classified, and credit for artemisinin's discovery was diffuse among hundreds of researchers. She held no PhD, had no overseas training, was not a member of any of China's national academies — a fact that earned her the nickname "the professor of three withouts" in Chinese science circles. But international recognition eventually arrived: the Lasker Award for Clinical Medical Research in 2011 was followed by the Nobel Prize in 2015, which she shared with Irish parasitologist William Campbell and Japanese microbiologist Satoshi Omura.

In her Nobel lecture, Tu Youyou was characteristically modest about her own role, emphasizing instead the value of traditional Chinese medicine as a treasury of therapeutic leads waiting to be validated by modern science. Her career stands as a rebuke to both extremes in the debate about traditional medicine — the dismissal of accumulated empirical knowledge and the uncritical acceptance of everything ancient. She showed that the ancient texts, read carefully and tested rigorously, could point to treatments that 2,000 years of clinical observation had identified and that modern science could refine into drugs of extraordinary power.

Now in her mid-nineties, Tu Youyou continues to work at the China Academy of Chinese Medical Sciences. Her discovery has catalyzed new research programs worldwide seeking further therapeutic leads in traditional pharmacopeias from China, Ayurveda, and African herbal medicine. She has demonstrated what might be the most important methodological insight of her era: that the answers to modern problems sometimes lie in ancient knowledge — not as received truth, but as a hypothesis worth testing.